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Aim:  To  determine  whether  early  clinical,  laboratory  and musculoskeletal  ultrasound  (MSUS)  character-
istics  can  be used  as early  detectors  of  juvenile  idiopathic  arthritis.
Patients  and  methods:  Forty  (40)  patients  with  juvenile  idiopathic  arthritis  (JIA)  diagnosed  according  to the
ILAR  criteria  [1]  and  20 healthy  control  children.  All  patients  were  subjected  to the following  assessment
at  base  line  and  at follow  up  after  6 months:  Clinical  evaluation,  MSUS  examination  and  laboratory
evaluation.
Results:  Of  the 40  patients,  6 patients  (15%)  had systemic  onset  subtype,  8 (20%)  oligoarticular  extended,  9
(22.5%) oligoarticular  persistent,  5 (12.5%)  polyarticular  rheumatoid  factor  (RF)  +ve,  6  (15%) polyarticular
RF  −ve,  5 (12.5%)  enthesitis  related  subtype  and  only  one  patient  (2.5%)  had psoriatic  JIA. MSUS  detected
more  synovitis  than  clinical  examination  (subclinical  synovitis)  both  at base  line  and  at  follow  up. MSUS
is  highly  sensitive  for  early  detection  of  joint  involvement  in  JIA  when  compared  to  physical  examination.
Signiﬁcant  decrease  in  the  mean  cartilage  thickness  of  the  patients  measured  at  follow  up as  compared
to  measures  at  base  line.
Conclusion:  MSUS  is  highly  sensitive  for  early  detection  of joint  involvement  in  JIA when  compared  to
physical  examination
©  2016  Published  by Elsevier  Ltd.  This is an  open  access  article  under  the  CC  BY-NC-ND  license. Introduction
Juvenile Idiopathic Arthritis (JIA) is a chronic inﬂammatory dis-
ase that affects 1 of every 1,000 children worldwide (Ravalli and
artini, 2007). [2] Joint inﬂammation has a central role in the
evelopment of cartilage damage and bony erosion. Although a
umber of measures are applied in the evaluation of disease activity
n, therapeutic decisions are primarily inﬂuenced by the presence
f synovitis on clinical examination JIA (Ravalli et al., 1997) [3].
urrently evaluation of the disease status in children with JIA is
ased on clinical and laboratory measures. However, these mea-
ures have the limitation of not directly measuring inﬂammation
t the primary site of pathology and may  be subject to confounding
nﬂuences. Imaging techniques, such as US and MRI, are capable of
irectly visualizing and objectively quantifying synovial inﬂamma-
ion and thus represent suitable tools to assess synovitis in children
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with JIA. These imaging modalities may  also enable better and
earlier detection of cartilage and bone changes than conventional
radiography (Magni-Manzoni et al., 2012) [4].
The issue of subclinical synovitis may  be particularly relevant in
JIA. In the International League of Associations for Rheumatology
classiﬁcation, children with JIA are deﬁned as having oligoarthritis
or polyarthritis on the basis of the number of affected joints (≤4 or
>4, respectively) (Giannini et al., 1992) [5]. Furthermore, the pres-
ence of active disease in a minimum of 5 joints is a prerequisite for
patient inclusion in clinical trials of second line or biologic agents
(Grassi, 2003), Lovell et al., 2008) [6,7]. Therefore, the presence of
subclinical disease in some joints may  alter patient classiﬁcation
or affect the identiﬁcation of patients requiring more aggressive
treatment.
1.1. Aim: of the workTo determine whether early clinical, laboratory and muscu-
loskeletal ultrasound (MSUS) characteristics can be used as early
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. Patients and methods
Forty patients with JIA and twenty subjects as a control group
ere included between Jun 2014 to April 2016, Twenty ﬁve (25)
emales and ﬁfteen (15) males, their age ranged from 2 to 15 years
ith a mean of 8.8 ± 3.6 years and disease duration ranged from
 weeks to three months. All patients were attending rheumatol-
gy and rehabilitation department at Minia university hospital. All
atients were diagnosed according to the ILAR criteria (Petty et al.,
998) [1] if well fulﬁlled at the 1 st presentation or in the follow up
fter 6 months. They were included in our study after approval of
he local ethical committee. An informed consent from each patient
as taken before enrollment into the study.
.1. Patient’s selection
Inclusion criteria: Forty children aged <16 years presenting with
ny of the following manifestations with duration ranged from 6
eeks to three months: Arthritis (in at least one joint), arthralgia,
kin rash, fever, psoriasis, sacroiliitis, enthesitis.
.2. Exclusion criteria
Septic arthritis, haemarthrosis, arthritis caused by malignancy
r trauma, connective tissue disorder such as systemic lupus ery-
hematosus, mixed connective tissue disease or dermatomyositis.
leven (11) children were excluded, 3 had juvenile lupus, 5 had
iral infection and 3 had post traumatic arthritis.
.3. Data collection
All patients were subjected to:
Initial assessment at base line and follow up assessment after 6
onths, where the following assessments were done for all patients
t base line and repeated at follow up after 6 months: Clinical eval-
ation, musculoskeletal ultrasonographic examination, laboratory
valuation.
The controls were subjected to: Musculoskeletal ultrasono-
raphic examination and laboratory evaluation.
.4. Locomotor system examination.
Each joint was examined by inspection (swelling, deformity,
edness or scar), palpation (effusion, synovial thickening, hotness
r tenderness), and movement (active and passive) with measure-
ent of the active range of motion.
Articular index (AI) score was calculated according to modiﬁed
itchie (AI) (Ritchie et al., 1968) [8].
Number of swollen joints was calculated.
Number of tender joints was calculated.
Number of joints with limited range of motion (LROM) was cal-
ulated.
Number of joints with clinical synovitis was calculated; a joint
ith clinical synovitis was deﬁned as the presence of swelling or, if
o swelling was present the presence of tenderness/pain on motion
nd LROM (Ruperto and Giannini, 1996;) [9] (Ravelli et al., 1997)
3].
Examination for enthesopathy (planter fascia, Achill’s tendon,
pinal process and iliac crest).
.5. Musculoskeletal Ultrasonographic evaluation:Ultrasonographic assessment was done for all patients at the 1st
resentation and at follow up and for the control; the following data
ere recorded for the right and left metacarpophalangeal joints,





2.5.1. Power Doppler signal (PDS)
US assessment was performed separately, immediately after
clinical evaluation, by the same experienced radiologist and
rheumatologist in musculoskeletal US (ﬁve years’ experience in
musculoskeletal US). The US examiner was blinded to clinical ﬁnd-
ings. Ultrasonographic examination was  performed using Semins
P300 Freq. up to 18MH linear transducer.
Joint effusion was deﬁned as the presence of an abnormally ane-
choic space within the joint that was  compressible. Bone erosion
was deﬁned as a cortical crater seen in two  views, Synovial mem-
brane thickness and articular cartilage thickness were measured
in mm and compared to age and sex matched healthy control.
Power Doppler signal was  considered positive in the presence of
vessel dots on PD images. All of the US ﬁndings were interpreted
using both longitudinal and transverse planes. The number of joints
with US effusion, erosions, increased synovial membrane thickness,
positive PD signal and decreased articular cartilage thickness were
computed.
A joint with US synovitis was deﬁned as a joint in which any of
the 5 US abnormalities was detectable. The US examination tech-
niques as well as the deﬁnitions of US features were based on
published guidelines and descriptions, particularly those provided
by the outcome measures in rheumatology clinical trials
(Wakeﬁeld et al., 2005 [10]; Naredo et al., 2007 [11]; Naredo
et al., 2008 [12]).
2.6. Laboratory evaluation:
The following laboratory investigations were done for patients
(at base line and at follow up) and control:
Complete blood count (CBC) using automated cell counter.
Estimation of ESR by the Westergren method.
Rheumatoid factor by latex agglutination slide test for the qual-
itative and semi quantitative determination of RF in non diluted
serum.
Liver and renal function tests as routine basic blood tests.
Antinuclear antibody titer and pattern (by immuno-ﬂuorescent
technique) (Aitcheson and Tan, 1982) [13].
Anti Cyclic Citrullinated Peptide antibody (Anti CCP), as follow
(Schellekens et al., 2000) [14]: Kits used: Cyclic Citrullinated Pep-
tide (CCP) IgG ELISA kit supplied from INOVA diagnostics, Inc.San
Diego, CA USA 92131.
2.7. Statistical analysis
Data were coded, entered and analyzed by the Statistical Pack-
age for the Social Sciences (SPSS for windows version 16.0) (SPSS
Inc., 2000). Two-tailed tests were used throughout, and statistical
signiﬁcance was set at the conventional level of less than 0.05.The
range, means and standard deviation were calculated for interval
and ordinary variables and frequencies and percentages for cat-
egorical variables (Bland, 1987) [15]. Comparisons were done by
several procedures, depending on the type of variables: Student’s
t-test and chi-squared (c2) test. Pearson’s correlation coefﬁcient
was done (Bland, 1987) [15]. Sensitivity, speciﬁcity, positive and
negative predictive values were calculated.





































PFig. 1. Represents the percenta
. Results
Girls were 25 (62.5%) and boys were 15 (37.5%). The age of
atients ranged from 2 to 15 years with a mean of 8.8 ± 3.6. Both
atients and control were age and sex matched (p = 0.90 & p = 0.85).
The percentage of onset subtypes in JIA patients was  repre-
ented on Fig. 1:
The disease duration was ranged from 6 to 12 weeks with a
ean of 7.6 ± 2.0 weeks. Family history was positive in 5 (12.5%)
f patients, 1 (2.5%) had oligoarticular subtype and 4 (10%) had
nthesitis related arthritis.
The main clinical presentation was arthralgia in 4 (10%) of the
0 patients, arthritis in 28 patients (70%), fever in 3 patients (7.5%),
kin rash in 2 patients (5%), and enthesitis in 3 patients (7.5%).
At base line, 5 patients (12.5%) were RF +ve and 35 (87.5%) were
F −ve, 14 patients (35%) were antinuclear antibodies (ANA) +ve
7 (50%) had homogenous ANA pattern, 4 (28.6%) speckled and
 (21.4%) nucleolar pattern} and 26 (65%) were −ve, 5 patients
12.5%) were anti CCP antibody +ve and 35 (87.5%) were −ve,
rythrocyte sedimentation rate (ESR) was elevated in 37 patients
92,5%), C-reactive protein (CRP) was positive in 32 patients (80%),
nemia was present in 6 patients (15%), while thrombocytosis was
resent in 5 patients (12.5%).
.1. Musculoskeletal Ultrasonographic ﬁndings
.1.1. Frequency of clinical and US features in speciﬁc joints at
ase line: (Tables 1–3)
In total, 400 joints {10 joints in every patient of the 40 patients
T and LT second proximal interphalangeal joint (PIP), RT and LT
econd metacarpophalangeal joint (MCP), RT and LT wrists, RT and
T knees, RT and LT ankles} were assessed both clinically and with
S at base line.
.1.1.1. Clinical ﬁndings. On clinical examination, 72 joints (18%)
ere swollen, 109 joints (27.25%) were tender, 26 joints (6.5%) had
imited range of motion (LROM), and 79 joints (19.75%) had clinical
ynovitis.
Among the 79 joints with clinical synovitis, the most frequently
ffected were the LT MCP  (15.18), followed by the LT wrist (13.92%)
nd RT wrist (13.92%), RT MCP  (12.65%), RT knee (11.39%), RT PIP
7.59%) and both ankles (7.59% for each), and the less frequently
ffected were the LT PIP (5.06%) and LT knee joints (5.06%)..1.1.2. US ﬁndings. On US evaluation, 116 joints (29% of the total
00 joints) had joint effusion, 39 joints (9.75%) had erosions, 102
oints (25.5%) had synovial hypertrophy, 57 joints (14.25%) had +ve
DS, 94 (23.5%) joints had decreased cartilage thickness (Fig. 1).onset subtypes in JIA patients.
A total of 123 joints (30.75%) had US synovitis (i.e., had 1 or
more of the 5 US abnormalities). Ultrasonic synovitis was seen most
frequently in the LT MCP  (13.82%), followed by the RT MCP  and RT
wrist joints (13.00% for each), RT knee (12.19%), LT wrist (9.75%),
LT ankle (8.94%), LT knee (8.13%), LT PIP and RT ankle (7.31%) and
the less frequently affected was  the RT PIP joint (6.50%).
3.1.2. Frequency of clinical and US features in speciﬁc joints at
follow up: (Table 3)
The same 400 joints were assessed both clinically and with US
at follow up.
3.1.2.1. Clinical ﬁndings. On clinical examination, 129 joints
(32.25%) were swollen, 184 joints (46%) were tender, 32 joints (8%)
had LROM, and 138 joints (34.5%) had clinical synovitis.
Among the 138 joints with clinical synovitis, the most frequently
affected was  the RT wrist (15.21)%), followed by the RT and LT MCP
joints (12.31% for each), RT knee‘ (11.59%), LT PIP and LT wrist (9.42%
for each), RT ankle (7.97%), LT ankle (8.69%), LT knee (7.24%) and the
less frequently affected was  the RT PIP (5.79%).
3.1.2.2. US ﬁndings. On US evaluation, 170 joints (42.5% of the total
400 joints) had joint effusion, 86 joints (21.5%) had erosions, 171
joints (42.75%) had synovial hypertrophy, 112 joints (28%) had +ve
PDS, 163 (40.75%) joints had decreased cartilage thickness.
A total of 183 joints (45.75%) had US synovitis. Ultrasonic syn-
ovitis was  seen most frequently in the RT wrist (13.11%), followed
by the RT knee (12.56%), LT MCP  and LT knee (10.92% for each), RT
MCP  (9.83%), LT wrist and LT ankle (9.28% for each), LT PIP and RT
ankle (8.19% for each),and the less frequently affected was the RT
PIP joint (7.65%).
Musculoskeletal ultrasonography led to classify 4 patients (had
only arthralgia on clinical examination without any clinical synovi-
tis) as oligoarticular persistent subtype, and also US  led to classify
2 patients (who had oligoarthritis by clinical examination) as pol-
yarticular RF +ve, and another 2 patients (who had oligoarthritis by
clinical examination) as polyarticular RF −ve JIA.
3.2. Correlation between the number of joints with US synovitis
and different clinical parameters (at follow up)
At follow up the number of joints with US synovitis had posi-
tive highly signiﬁcant correlation with the number of swollen joints
(p=0.000**), number of tender joints (p=0.000**), number of joints
with clinical synovitis (p=0.000**), number of joints with LROM
(p=0.006**), Ritchie AI (p=0.000**) and duration of morning stiff-
ness (p=0.002**). The mean cartilage thickness measured in JIA
patients at follow up was  signiﬁcantly lower in all examined joints
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Table  1
Clinical data of patients at base line and at follow up.
At base line At follow up P-value
Morning stiffness(min) Range 0.00–165.0 0.00–180 0.141
Mean ± SD 28.50 ± 70.24 68.12 ± 79.53
Ritchie AI Range 1.00–19.00 2.00–25.00 0.000**
Mean ±SD 6.65 ± 5.86 11.57 ± 7.29
N.  of swollen J. Range 0.00–5.00 0.00–7.00 0.000**
Mean ±SD 1.77 ± 1.76 3.17 ± 2.07
N.  of tender J. Range 0.00–7.00 0.00–8.00 0.093
Mean ±SD 3.17 ± 0.55 3.45 ± 1.16
N.  of J. with clinical synovitis Range 0.00–6.00 0.00–7.00 0.000**
Mean ±SD 1.95 ± 1.86 3.35 ± 2.20
N.  of J. with LROM Range 0.00–5.00 0.00–6.00 0.618
Mean ±SD 1.67 ± 0.82 1.75 ± 0.98
Morning stiffness Yes 26(65%) 19(47.5%) 0.115
No  14(35%) 21(52.5%)
Fever Yes 8(20%) 5(12.5%) 0.636
No  32(80%) 35(37.5%)
Skin rash Yes 7(17.5%) 5(12.5%) 0.531
No  33(82.5%) 35(37.5%)
Uveitis Yes 11(27.5%) 8(20%) 0.431
No  29(72.5%) 32(80%)
Enthesitis Yes 10(25%) 7(17.5%) 0.412
No  30(75%) 33(82.5%)
** Signiﬁcant P-value < 0.01.
Table 2
Ultrasonography determined synovitis in clinically symptomatic and asymptomatic joints.
At base line At follow up
Joints with clinical




synovitis (n = 138)
Clinically asymptomatic joints
(n = 262)
N. of joints with US
synovitis
79 (100%) 44 (13.7%) 138 (100%) 45 (17.17%)
Table 3
Clinical and US examination in detection of synovitis in different JIA subtypes at follow up.
JIA subtype Patients with clinical synovitis (n = 30) Patients with US synovitis (n = 38)
Number % Number %
Systemic onset 6 20 6 15.78
Oligoarticular extended 8 26.66 8 21.05
Oligoarticular persistent 5 16.66 9 23.68
Polyarticular RF +ve 3 10 5 13.15
Polyarticular RF −ve 4 
ERJIA  3 
PsJIA  1 
Table 4
The sensitivity, speciﬁcity, positive and negative predictive values of clinical exam-












Ultrasonography is ideally suited for multiple joint assessment.Positive predictive value 1 1
LT and RT PIPs, LT and RT MCPs, LT and RT wrists, LT and RT knee
nd LT and RT ankles) compared with the healthy control group
igs. 4 and 5.
.3. Correlation by clinical examination and US evaluation for
etection of synovitis
The sensitivity of clinical examination reached 34.5% compared
o 45.7% for the MSUS with speciﬁcity of 100% for both. The +ve
redictive value was 1 for each while the −ve predictive value
as 0.43 for clinical examination compared to 0.47 for MSUS.13.33 6 15.78
10 3 7.89
3.33 1 2.63
(Table 4) Different degrees and joint involvements were repre-
sented in Figs. 2, 3, and 5.
4. Discussion
In the past decade, there has been important progress in the
management of JIA, which includes the shift towards early aggres-
sive interventions, and the development of new therapeutic agents
and combination treatment strategies (Hayward and Wallace, 2009
[16]). A reliable documentation of the advances in therapeutic
effectiveness creates the need for sensitive methods that enable
a precise monitoring of the course of the synovial inﬂammation
process. Furthermore, it is desirable to identify patients with a
high likelihood of developing erosive joint damage early, so as to
institute appropriately aggressive therapy at an early stage of the
disease. Of the diagnostic tools currently available, imaging studies
are best suited for these purposes (Ruperto and Martini, 2011) [17].It has been suggested that its routine use allows a marked improve-
ment of a clinician’s capability to detect both early and hidden
features of synovitis (Grassi, 2003) [6].
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Fig. 2. a- Effusion in the 2nd MCP joint (Thick short arrow). b- 2nd MCP  effusion with erosion of the metacarpal head (arrow). c- Synovial hypertrophy in 2nd MCP  joint with
















sFig. 3. a- Synovial hypertrophy in the 
Silvia et al. (2009) [18], compared clinical and US examination
f multiple joints in children with JIA where thirty two  patients
nderwent clinical and US evaluation of 52 joints. They found that
S detected more synovitis than clinical examination. Of the 1664
canned joints, 104 (6.25%) had clinical synovitis and 167 (10.0%)
ad US synovitis. Furthermore, 86 (51.5%) of the 167 joints that had
S documented synovitis were clinically normal (i.e., had subclin-
cal synovitis). Subclinical synovitis was more common in small
and and wrist joints. Notably, discrepancies between pediatric
heumatologists in clinical examination of joints in children with
IA were found to be larger in small hand joints (Guzman et al.,
995) [19].
Detecting synovitis in clinically unaffected joints, US may
ncrease the number of patients who are candidates to receive
econd line or biologic agents. Another important issue that may
e affected by US application is the assessment of clinical remis-
ion. The absence of joints with active arthritis, deﬁned on clinicalIP joint. b- 2nd PIP joint with effusion.
grounds, is a fundamental component of criteria for inactive disease
in JIA (Wallace et al., 2004) [20].
Our data support previous studies which indicate that US is able
to detect subclinical disease (Magni et al., 2009 [21]; Filippou et al.,
2011)[22].
Our study revealed that MSUS is highly sensitive for early
detection of joint involvement in JIA when compared to physical
examination.
This goes in concordance with the study by Ginger et al.
(2011)[23], which aimed to determine sensitivity and speciﬁcity of
the physical examination (PE) for identifying synovitis in the knee
and ankle joints of children with JIA. Nineteen patients with JIA
were referred for US. Both knees and ankles were examined using
US. They found that there was  agreement between US  and PE in 75%
of cases. PE was 64% sensitive and 86% speciﬁc for identifying active
arthritis. physical examination was  100% speciﬁc if (1) the patient
was positive for both PE criteria. When the PE was negative and
the US was  positive, 21.4% developed active disease on PE within
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PFig. 5. Represents comparison between joint cartilage thickness measu
 months. Limitations of this study were that neither the sonogra-
her nor the interpreting radiologists were blinded to the patient’s
iagnosis. Synovitis was not conﬁrmed by another imaging tech-
ique, no US was performed at the time of the follow up. Moreover
E was performed by more than 1 clinician so that interobserver MSUS in patients (at follow up) and control group (values are in mm).
disagreement may  have been present. While in the current study
we performed US at the time of follow up, and PE was performed
by only 1 clinician so that there is no interobserver disagreement.
The ﬁndings in our study have important implications for
the classiﬁcation of JIA. Currently, the number of joints affected
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ver time is adopted as a criterion to classify patients in pre-
umably homogeneous categories. Patients are deﬁned as having
ligoarthritis or polyarthritis if they have 4 or fewer or 5 or more
oints involved, respectively, during the ﬁrst 6 months of disease
Petty et al., 2004) [24].
We found that US led to classify 4 patients (had only arthralgia
n clinical examination without any clinical synovitis) as oligoar-
icular persistent subtype, and also US led to classify 2 patients
who had oligoarthritis by clinical examination) as polyarticular
F +ve, and another 2 patients (who had oligoarthritis by clinical
xamination) as polyarticular RF −ve JIA.
Similarly, in the study of Silvia M et al. (2009)[18], US led them
o classify 5 patients who were labeled as having oligoarthritis or
ere found to have no synovitis on clinical examination as having
olyarthritis. In another study in JIA, 36% of clinically normal knees
ad evidence of effusion on US (McCarron et al., 2008) [25]. these
ndings suggest that US is more accurate than clinical assessment
nd may  lead to reclassifying many patients with JIA. Furthermore,
hey add to the criticisms about the use of the number of affected
oints as a classiﬁcation parameter in JIA (Martini, 2003) [26].
The study of Silvia et al. (2009) [18], had some limitations which
hould be mentioned. The relationship between clinical and US
ndings was evaluated in a cross sectional assessment. Therefore,
hey could not investigate the predictive value of US in relation to
he efﬁcacy of therapeutic interventions or course of joint disease
ver time. A healthy control group, which would have strength-
ned the study, was not available. This is in contrast to our study in
hich we did a follow up US assessment; therefore, we could inves-
igate the predictive value of US, and a healthy control group was
xamined to strengthen the study. However both studies did not
alidate the additional synovitis by other imaging techniques, such
s MRI. Although this technique is limited by its inability to scan
ore than one joint and general anesthesia is required in younger
hildren.
In our study the mean cartilage thickness measured in the JIA
atients at follow up was signiﬁcantly lower in all examined joints
ompared with the healthy control group.
Dan #XPS##x00D8;stergaard et al. (2013) [27], found that, Joint
artilage thickness was decreased in the knee, wrist, and second
IP joint in children with JIA compared with the healthy cohort
p < 0.001 for all). Whereas the cartilage thickness in the ankle
nd second MCP  joint was not different from that of healthy con-
rols. Interestingly, regardless of whether the knees, wrists, and
econd PIP joints were ever previously affected, they found sig-
iﬁcantly decreased cartilage thickness compared to similar joints
rom healthy controls.
A limitation of this study by Dan #XPS##x00D8;stergaard et al.
2013) [27], was that the US measurements were done by 1
bserver who measured joint cartilage thickness in healthy chil-
ren and 1 who did the measurements in the patients with JIA so
hat interobserver disagreement may  have been present. However
he investigators were blinded to clinical information about JIA sub-
ype, disease activity, age, and sex. This limitation was  not present
n our study.
We found that, number of joints with US synovitis was  signiﬁ-
antly correlated with different clinical features. Silvia et al. (2009)
18], found that US ﬁndings were moderately correlated with clin-
cal measures of joint swelling, but poorly correlated with those of
oint tenderness/pain on motion and restricted motion.
We should emphasize that our results do not mean that US is an
lternative to clinical examination. It should be regarded as a tool
hat complements conventional clinical examination.US has several advantages over other imaging techniques for
se in paediatric subjects, which include non-invasiveness, rapid-
ty of performance, ease of repeatability, high patient acceptability
nd lack of exposure to ionizing radiation. In addition, it does not
[
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require sedation for scanning in younger children. US allows pre-
cise and thorough visualization of inﬂammatory and destructive
joint abnormalities, including synovial hyperplasia, joint effusion,
cartilage damage, bone erosion, tenosynovitis and enthesopathy
(Filippucci et al., 2007 [28]).
Finally, the signiﬁcance of new results when compared to recent
studies can be as follow: Our results included children’s very early
onset of disease and re-evaluate them after 6 months (short term
evaluation). It is useful to use US for reclassiﬁcation of the types
of juvenile arthritis early which is important for disease progno-
sis. Assessment included 5 different joints rather other studies and
clinical parameters were assessed and correlated with US  ﬁndings.
5. Conclusions
MSUS is highly sensitive for early detection of joint involvement
in JIA when compared to physical examination. Subclinical synovi-
tis as detected by US is common in children with JIA. This ﬁnding
may  have important implications for patient classiﬁcation. Abnor-
mal  US ﬁndings are signiﬁcantly correlated with different clinical
features
We recommend the use of MSUS for early detection of synovi-
tis in JIA, however MSUS training focused on the assessment of
pediatric patients and standardization of US assessment of joints
in children might be very important in implementing the use of
this technique in clinical practice and research. Studies on larger
groups of children are needed to conﬁrm the validation and vari-
ability of US in children. Moreover, longitudinal assessments are
required to determine the true signiﬁcance of subclinical disease
as determined by MSUS in JIA.
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